|
 |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
FDA approves Novartis drug Glivec
 |
|
| FDA has approved an update to the Glivec (imatinib) label by Novartis to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors |
|
 |
|
|
| |
| FDA approves BYDUREON for type 2 diabetes
|
|
| US based Amylin Pharmaceuticals and Alkermes have announced that the US Food and Drug Administration has approved BYDUREON (exenatide extended-release for injectable suspension) the first once-weekly treatment for type 2 diabetes |
|
|
|
|
| |
|
|
| |
|
|
| More |
